Cargando…

Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway

Nuclear factor- (erythroid-derived 2) like 2 (NFE2L2, NRF2) is a key transcriptional activator of the antioxidant response pathway and is closely related to erythroid transcription factor NFE2. Under oxidative stress, NRF2 heterodimerizes with small Maf proteins and binds cis-acting enhancer sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Michelle R., Karaca, Mehmet, Adamski, Kelly N., Chorley, Brian N., Wang, Xuting, Bell, Douglas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677633/
https://www.ncbi.nlm.nih.gov/pubmed/23766848
http://dx.doi.org/10.1155/2013/120305
_version_ 1782272750018101248
author Campbell, Michelle R.
Karaca, Mehmet
Adamski, Kelly N.
Chorley, Brian N.
Wang, Xuting
Bell, Douglas A.
author_facet Campbell, Michelle R.
Karaca, Mehmet
Adamski, Kelly N.
Chorley, Brian N.
Wang, Xuting
Bell, Douglas A.
author_sort Campbell, Michelle R.
collection PubMed
description Nuclear factor- (erythroid-derived 2) like 2 (NFE2L2, NRF2) is a key transcriptional activator of the antioxidant response pathway and is closely related to erythroid transcription factor NFE2. Under oxidative stress, NRF2 heterodimerizes with small Maf proteins and binds cis-acting enhancer sequences found near oxidative stress response genes. Using the dietary isothiocyanate sulforaphane (SFN) to activate NRF2, chromatin immunoprecipitation sequencing (ChIP-seq) identified several hundred novel NRF2-mediated targets beyond its role in oxidative stress. Activated NRF2 bound the antioxidant response element (ARE) in promoters of several known and novel target genes involved in iron homeostasis and heme metabolism, including known targets FTL and FTH1, as well as novel binding in the globin locus control region. Five novel NRF2 target genes were chosen for followup: AMBP, ABCB6, FECH, HRG-1 (SLC48A1), and TBXAS1. SFN-induced gene expression in erythroid K562 and lymphoid cells were compared for each target gene. NRF2 silencing showed reduced expression in lymphoid, lung, and hepatic cells. Furthermore, stable knockdown of NRF2 negative regulator KEAP1 in K562 cells resulted in increased NQO1, AMBP, and TBXAS1 expression. NFE2 binding sites in K562 cells revealed similar binding profiles as lymphoid NRF2 sites in all potential NRF2 candidates supporting a role for NRF2 in heme metabolism and erythropoiesis.
format Online
Article
Text
id pubmed-3677633
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36776332013-06-13 Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway Campbell, Michelle R. Karaca, Mehmet Adamski, Kelly N. Chorley, Brian N. Wang, Xuting Bell, Douglas A. Oxid Med Cell Longev Research Article Nuclear factor- (erythroid-derived 2) like 2 (NFE2L2, NRF2) is a key transcriptional activator of the antioxidant response pathway and is closely related to erythroid transcription factor NFE2. Under oxidative stress, NRF2 heterodimerizes with small Maf proteins and binds cis-acting enhancer sequences found near oxidative stress response genes. Using the dietary isothiocyanate sulforaphane (SFN) to activate NRF2, chromatin immunoprecipitation sequencing (ChIP-seq) identified several hundred novel NRF2-mediated targets beyond its role in oxidative stress. Activated NRF2 bound the antioxidant response element (ARE) in promoters of several known and novel target genes involved in iron homeostasis and heme metabolism, including known targets FTL and FTH1, as well as novel binding in the globin locus control region. Five novel NRF2 target genes were chosen for followup: AMBP, ABCB6, FECH, HRG-1 (SLC48A1), and TBXAS1. SFN-induced gene expression in erythroid K562 and lymphoid cells were compared for each target gene. NRF2 silencing showed reduced expression in lymphoid, lung, and hepatic cells. Furthermore, stable knockdown of NRF2 negative regulator KEAP1 in K562 cells resulted in increased NQO1, AMBP, and TBXAS1 expression. NFE2 binding sites in K562 cells revealed similar binding profiles as lymphoid NRF2 sites in all potential NRF2 candidates supporting a role for NRF2 in heme metabolism and erythropoiesis. Hindawi Publishing Corporation 2013 2013-05-25 /pmc/articles/PMC3677633/ /pubmed/23766848 http://dx.doi.org/10.1155/2013/120305 Text en Copyright © 2013 Michelle R. Campbell et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Campbell, Michelle R.
Karaca, Mehmet
Adamski, Kelly N.
Chorley, Brian N.
Wang, Xuting
Bell, Douglas A.
Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
title Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
title_full Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
title_fullStr Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
title_full_unstemmed Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
title_short Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
title_sort novel hematopoietic target genes in the nrf2-mediated transcriptional pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677633/
https://www.ncbi.nlm.nih.gov/pubmed/23766848
http://dx.doi.org/10.1155/2013/120305
work_keys_str_mv AT campbellmicheller novelhematopoietictargetgenesinthenrf2mediatedtranscriptionalpathway
AT karacamehmet novelhematopoietictargetgenesinthenrf2mediatedtranscriptionalpathway
AT adamskikellyn novelhematopoietictargetgenesinthenrf2mediatedtranscriptionalpathway
AT chorleybriann novelhematopoietictargetgenesinthenrf2mediatedtranscriptionalpathway
AT wangxuting novelhematopoietictargetgenesinthenrf2mediatedtranscriptionalpathway
AT belldouglasa novelhematopoietictargetgenesinthenrf2mediatedtranscriptionalpathway